How to treat Diabetes?

Fetí sí ojúewé yìí

Báwo la ṣe lè wo àrùn àtọ̀gbẹ sàn?

Láti wo àrùn àtọ̀gbẹ sàn, ó ṣe pàtàkì láti tẹ̀ lé ọ̀nà tó gbòòrò gan-an tó ní í ṣe pẹ̀lú ìyípadà nínú ọ̀nà ìgbésí ayé, lílo oògùn, àti ṣíṣe àyẹ̀wò déédéé.

Àwọn ìgbésẹ̀ kan rèé tó lè ràn ẹ́ lọ́wọ́ láti kojú àrùn àtọ̀gbẹ:

1. Ìyípadà nínú ọ̀nà ìgbésí ayé:

- Máa jẹun bó ṣe yẹ: Máa yan àwọn oúnjẹ tí kò fi bẹ́ẹ̀ ní ọ̀rá àti kálórì, tó sì ní ọ̀pọ̀lọpọ̀ èròjà ara, irú bí èso, ewébẹ̀, àti ọkà.

- Máa máa ṣe eré ìmárale déédéé: Máa ṣe eré ìmárale tó pọ̀ tó ọgbọ̀n ìṣẹ́jú lọ́sọ̀ọ̀ọ̀sẹ̀, irú bí rírìn kánkán.

- Gbigba iwuwo ti o dara: Pipadanu iwuwo le ṣe iranlọwọ lati mu imọlara insulin ati iṣakoso suga ẹjẹ dara si.

- Máa mu sìgá mọ́: Bíbá sìgá mu máa ń mú kí ewu àwọn ìṣòro tó ní í ṣe pẹ̀lú àrùn àtọ̀gbẹ pọ̀ sí i.

2. Àwọn oògùn tí wọ́n ń lò:

- Àwọn oògùn tí a máa ń mu: Àwọn oògùn yìí lè ṣèrànwọ́ láti dín iye ṣúgà tó wà nínú ẹ̀jẹ̀ kù nípa fífi ìdásílẹ̀ insulin kún, fífi ìfọkànbalẹ̀ insulin kún, tàbí kí wọ́n dín ìmúná glucose kù.

- Ìtọjú insulin: àwọn èèyàn tó ní àrùn àtọ̀gbẹ oríṣi 1 àti àwọn kan tó ní àrùn àtọ̀gbẹ oríṣi 2 lè nílò ìmúná insulin tàbí ìmúná insulin.

3. Àkíyèsí:

- Ìdánwò ṣúgà nínú ẹ̀jẹ̀ déédéé: Ṣàyẹ̀wò iye ṣúgà nínú ẹ̀jẹ̀ rẹ gẹ́gẹ́ bí olùrànlọ́wọ́ ìlera rẹ ṣe dábàá.

- Ìwádìí déédéé: Wá lọ sọ́dọ̀ olùtọ́jú ìlera rẹ fún àyẹ̀wò déédéé láti ṣàkíyèsí àrùn àtọ̀gbẹ rẹ àti ìlera rẹ lápapọ̀.

4. Ṣe àbójútó àwọn ìṣòro:

- Ṣe àbójútó ìfúnpá ẹ̀jẹ̀ àti cholesterol rẹ láti dín ewu àìsàn ọkàn àti àrùn ọpọlọ kù.

- Ṣọ́ra fún ẹsẹ̀ rẹ láti dènà ìpalára sí àwọn iṣan ara àti àìsàn.

- Ìdánwò ojú déédéé láti ṣàwárí àti láti wo àìsàn retinopathy tí àrùn àtọ̀gbẹ ń fà.

5. Ìrànlọ́wọ́:

- Darapọ̀ mọ́ ẹgbẹ́ olùrànlọ́wọ́ kan tàbí bá olùrànlọ́wọ́ kan sọ̀rọ̀ láti ràn ẹ́ lọ́wọ́ láti bójú tó àwọn nǹkan tó máa ń fà á tó o bá ní àrùn àtọ̀gbẹ.

- Máa bá olùkọ́ nípa àrùn àtọ̀gbẹ sọ̀rọ̀ kó o lè mọ púpọ̀ sí i nípa bí o ṣe lè bójú tó àìsàn rẹ.

Rántí pé ó ṣe pàtàkì kó o bá oníṣègùn rẹ ṣiṣẹ́ pa pọ̀ láti ṣe ètò ìtọ́jú kan tó bá ọ mu jù lọ.

Àwọn ìtumọ̀

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Handorf AM, Sollinger HW, Alam T: Insulin gene therapy for type 1 diabetes mellitus. Exp Clin Transplant. 2015, 13 Suppl 1 (): 37-45.

Galakhov EV, Zhiliaeva EP: [Problems concerning the training of feldshers in foreign countries]. Feldsher Akush. 1975, 40 (9): 37-41.

Ceriello A, Barkai L, Christiansen JS, Czupryniak L, Gomis R, Harno K, Kulzer B, Ludvigsson J, Némethyová Z, Owens D, Schnell O, Tankova T, Taskinen MR, Vergès B, Weitgasser R, Wens J: Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract. 2012, 98 (1): 5-10.

McElduff A: Type 2 diabetes mellitus: an evolving therapeutic approach. P N G Med J. , 44 (3-4): 124-30.

Koskinas K, Melmer A, Steiner N, Gübeli A, Wilhelm M, Laimer M: [Diagnosis, Prevention and Treatment of Cardiovascular Disease in People with Diabetes and Prediabetes]. Praxis (Bern 1994). 2021, 110 (1): 37-47.

Filippi CM, von Herrath MG: Strategies to treat autoimmune diabetes. Expert Rev Endocrinol Metab. 2007, 2 (2): 185-194.

Tibaldi J: Intensifying treatment in poorly controlled type 2 diabetes mellitus: case reports. Am J Med. 2008, 121 (6 Suppl): S30-4.

Verrotti A, Chiuri RM, Blasetti A, Mohn A, Chiarelli F: Treatment options for paediatric diabetes. Expert Opin Pharmacother. 2010, 11 (15): 2483-95.

Nadeau DA: Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes. Postgrad Med. 2010, 122 (3): 7-15.

Ìyàsímímọ́: ìtọ́jú ìlera

Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.

A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.

Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.

Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.

Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.

Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.

A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).

DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;

(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;

ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.

Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.

Ìfọ̀rọ̀wérọ̀

Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.

How to treat diabetes?

To treat diabetes, it is important to follow a comprehensive approach that includes lifestyle changes, medication, and regular monitoring.

Here are some steps that can help manage diabetes:

1. Lifestyle changes:

- Eat a healthy diet: Choose foods that are low in fat and calories, and high in fiber, such as fruits, vegetables, and whole grains.

- Exercise regularly: Aim for at least 30 minutes of moderate-intensity physical activity, such as brisk walking, most days of the week.

- Maintain a healthy weight: Losing weight can help improve insulin sensitivity and blood sugar control.

- Quit smoking: Smoking increases the risk of diabetes-related complications.

2. Medication:

- Oral medications: These can help lower blood sugar levels by increasing insulin production, increasing insulin sensitivity, or decreasing glucose absorption.

- Insulin therapy: Insulin injections or an insulin pump may be necessary for people with type 1 diabetes and some with type 2 diabetes.

3. Monitoring:

- Regular blood sugar testing: Check your blood sugar levels as recommended by your healthcare provider.

- Regular checkups: Visit your healthcare provider for regular checkups to monitor your diabetes and overall health.

4. Manage complications:

- Keep your blood pressure and cholesterol under control to reduce the risk of heart disease and stroke.

- Take care of your feet to prevent nerve damage and infections.

- Regular eye exams to detect and treat diabetic retinopathy.

5. Support:

- Join a support group or talk to a counselor to help manage the emotional aspects of living with diabetes.

- Work with a diabetes educator to learn more about managing your condition.

Remember, it is important to work closely with your healthcare provider to develop a personalized treatment plan that works best for you.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.